Physician profile
Robert A Joy
NPI 1073527289
$9,845.79
in general payments reported to CMS, 2019-2025
31 companies · $3,673 in 2025
The $3,673 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,404 · 2020: $248 · 2021: $439 · 2022: $1,072 · 2023: $2,752 · 2024: $256 · 2025: $3,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,857 · Food and Beverage: $2,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,857.16 |
| Food and Beverage | $2,824.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,560.12 | 2022-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Micra |
| Abbott Laboratories | $1,560.66 | 2019-2025 | Aveir, Ensite, Navitor |
| Boston Scientific Corporation | $427.99 | 2019-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Janssen Pharmaceuticals, INC | $396.75 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $305.38 | 2019-2024 | |
| Abiomed | $278.79 | 2019-2025 | Impella |
| Regeneron Healthcare Solutions, INC. | $233.33 | 2019 | |
| Amgen INC. | $232.66 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.05 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.12 | 2019-2024 | Lifevest |
| Chiesi USA, INC. | $216.94 | 2019-2023 | Cleviprex, Kengreal |
| Medtronic Vascular, INC. | $200.31 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $136.19 | 2019-2025 | Camzyos, Eliquis |
| Biosense Webster, INC. | $131.10 | 2021-2025 | Carto 3 |
| Merck Sharp & Dohme LLC | $99.12 | 2023-2025 | Verquvo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $95.90 | 2019-2022 | |
| Terumo Medical Corporation | $80.90 | 2021-2024 | Angio-Seal |
| Esperion Therapeutics, INC. | $72.62 | 2021-2022 | |
| Pfizer INC. | $67.55 | 2019-2022 | |
| Edwards Lifesciences Corporation | $56.50 | 2019 | |
| Cardiva Medical, INC. | $43.13 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Irhythm Technologies, INC. | $26.88 | 2022 | |
| Cardiovascular Systems INC. | $24.65 | 2021 | |
| Lilly USA, LLC | $24.62 | 2025 | Zepbound |
| Amarin Pharma, INC. | $21.35 | 2020 | |
| Kiniksa Pharmaceuticals, Ltd. | $18.33 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $15.76 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.52 | 2024 | Onpattro |
| Teleflex LLC | $14.49 | 2023 | Manta |
| Scpharmaceuticals INC. | $14.40 | 2023 | |
| Silk Road Medical, INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Joy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.